ARZERRA Trademark

Trademark Overview

On Tuesday, November 25, 2008, a trademark application was filed for ARZERRA with the United States Patent and Trademark Office. The USPTO has given the ARZERRA trademark a serial number of 77621275. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 2, 2021. This trademark is owned by Glaxo Group Limited. The ARZERRA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical and medicinal preparations and substances to treat cancer
arzerra

General Information

Serial Number77621275
Word MarkARZERRA
Filing DateTuesday, November 25, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 2, 2021
Registration Number3842291
Registration DateTuesday, August 31, 2010
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 28, 2009

Trademark Statements

Indication of Colors claimedThe color(s) green, yellow, red and white is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the term "ARZERRA" in green with a green arrow with a white point above the term "ARZERRA" in the direction of left to right and a fanciful representation of a biological structure in the colors yellow and red with white indicating reflection appearing to the right side of the term "ARZERRA".
Goods and Servicespharmaceutical and medicinal preparations and substances to treat cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 2, 2021
Primary Code005
First Use Anywhere DateMonday, November 23, 2009
First Use In Commerce DateMonday, November 23, 2009

Trademark Owner History

Party NameNOVARTIS PHARMA AG
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
Address4056 BASEL 07936
CH
Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN

Trademark Events

Event DateEvent Description
Friday, April 2, 2021CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, August 31, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, February 2, 2017NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Thursday, February 2, 2017POST REGISTRATION ACTION MAILED - SEC. 7
Thursday, February 2, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, January 9, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 2, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, August 29, 2016TEAS SECTION 8 RECEIVED
Thursday, August 11, 2016TEAS SECTION 7 REQUEST RECEIVED
Thursday, June 2, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 2, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 17, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, August 31, 2015COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 7, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 7, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 7, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 7, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 31, 2010REGISTERED-PRINCIPAL REGISTER
Friday, July 30, 2010NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, July 29, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, July 28, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, July 8, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 7, 2010STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 23, 2010USE AMENDMENT FILED
Wednesday, July 7, 2010EXTENSION 2 GRANTED
Tuesday, March 23, 2010EXTENSION 2 FILED
Friday, June 25, 2010APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 12, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 23, 2010TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, March 23, 2010TEAS EXTENSION RECEIVED
Tuesday, March 23, 2010TEAS STATEMENT OF USE RECEIVED
Tuesday, March 2, 2010EXTENSION 1 GRANTED
Wednesday, January 20, 2010EXTENSION 1 FILED
Wednesday, January 20, 2010TEAS EXTENSION RECEIVED
Tuesday, March 2, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 6, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 6, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 21, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 12, 2009ASSIGNED TO EXAMINER
Tuesday, April 28, 2009PUBLISHED FOR OPPOSITION
Wednesday, April 8, 2009NOTICE OF PUBLICATION
Friday, March 20, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 20, 2009ASSIGNED TO LIE
Friday, March 20, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 20, 2009EXAMINER'S AMENDMENT ENTERED
Friday, March 20, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 20, 2009EXAMINERS AMENDMENT E-MAILED
Friday, March 20, 2009EXAMINERS AMENDMENT -WRITTEN
Thursday, February 26, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 26, 2009NON-FINAL ACTION E-MAILED
Thursday, February 26, 2009NON-FINAL ACTION WRITTEN
Wednesday, February 25, 2009ASSIGNED TO EXAMINER
Tuesday, December 2, 2008NOTICE OF DESIGN SEARCH CODE MAILED
Monday, December 1, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

arzerra treat cancer substances preparations medicinal pharmaceutical